Rare diseases
Investigational molecules
Locations
Back to Austria28 clinical trials in Wiener Neustadt, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
AustriaAustriaAustriaAustriaAustriaAustriaAustriaAustriaAustriaAustriaAustriaAustriaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on colorectal cancer treatments, including studies evaluating new combination therapies with immunotherapy agents. Investigations target both MSS/pMMR and KRAS G12C mutations.
Novel therapeutic approaches combining targeted treatments with established protocols.
Advanced studies in blood cancers, particularly focusing on multiple myeloma and follicular lymphoma. Research includes innovative combination therapies and comparative effectiveness studies.
Emphasis on improving outcomes for newly diagnosed patients and those requiring alternative treatment options.
Innovative trials examining treatments for HER2-negative breast cancer, including studies of new therapeutic agents and combination approaches for both early-stage and metastatic disease.
Focus on personalized treatment strategies and targeted therapies.
Comprehensive research involving multiple cancer types, including solid tumors across various organs. Studies evaluate novel therapeutic combinations and immunotherapy approaches.
Integration of innovative treatment modalities across different cancer types.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
